Trial · NCT04362085
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Composite Outcome of ICU Admission, Non-invasive Positive Pressure Ventilation, Invasive Mechanical Ventilation, or All-cause Death up to 28 Days. | Up to 28 days | Composite outcome of ICU admission, non-invasive positive pressure ventilation, invasive mechanical ventilation, or all-cause death up to 28 days. |
| Secondary | All-cause Death | Up to 28 days | All-cause death |
| Secondary | Composite Outcome of ICU Admission or All-cause Death | Up to 28 days | Composite outcome of ICU admission or all-cause death |
| Secondary | Composite Outcome of Mechanical Ventilation or All-cause Death | Up to 28 days | Composite outcome of mechanical ventilation or all-cause death |
| Secondary | Major Bleeding | Up to 28 days | Major bleeding as defined by the ISTH Scientific and Standardization Committee (ISTH-SSC) recommendation |
| Secondary | Red Blood Cell Transfusion | Up to 28 days | Red Blood Cell transfusion (greater than or equal to 1 unit) |
| Secondary | Transfusion of Platelets, Frozen Plasma, Prothrombin Complex Concentrate, Cryoprecipiate and/or Fibrinogen Concentrate | Up to 28 days | Transfusion of platelets, frozen plasma, prothrombin complex concentrate, cryoprecipiate and/or fibrinogen concentrate |
| Secondary | Renal Replacement Therapy | Up to 28 days | Renal replacement therapy defined as continuous renal replacement therapy or intermittent hemodialysis |
| Secondary | Hospital-free Days Alive up to Day 28 | Up to 28 days | Hospital-free days alive up to day 28 |
| Secondary | ICU-free Days Alive up to Day 28 | Up to 28 days | ICU-free days alive up to day 28 |
| Secondary | Ventilator-free Days Alive up to Day 28 | Up to 28 days | Ventilator-free days alive up to day 28 |
| Secondary | Organ Support-free Days Alive up to Day 28 | Up to 28 days | Organ support-free days alive up to day 28 |
| Secondary | Venous Thromboembolism | Up to 28 days | Venous thromboembolism |
| Secondary | Arterial Thromboembolism | Up to 28 days | Arterial thromboembolism |
| Secondary | Heparin Induced Thrombocytopenia | Up to 28 days | Heparin induced thrombocytopenia |
| Secondary | Changes in D-dimer | Up to day 3 | Geometric mean ratio defined as ratio of geometric means of D-dimer ratios (D-dimer×ULN) of day 2 ±24 hours post-randomisation, adjusted for baseline geometric means of D-dimer ratios using analysis of covariance. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04362085/registered